
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Institute of Pathology, National University Hospital; 2 Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway; and 3 NorChip AS, Klokkarstua, Norway
Requests for reprints: Tor Molden, Institute of Pathology, National University Hospital, Sognsveien 20, 0027 Oslo, Norway. Phone: 47-40403484; Fax: 011-47-32798801. E-mail: t.e.f.molden{at}labmed.uio.no
The purpose of this study was to compare the detection of human papillomavirus (HPV) DNA with detection of mRNA. The study included 4,136 women >30 years of age. E6/E7 mRNA expression from the carcinogenic HPV types 16, 18, 31, 33, and 45 was detected by the PreTect HPV-Proofer assay, whereas the presence of HPV DNA was detected by Gp5+/6+ consensus PCR followed by type-specific PCR. A total of 4.0% had an abnormal cytologic diagnosis, 3.0% were positive by PreTect HPV-Proofer, 4.4% by type-specific PCR, and 10.4% by consensus PCR. For detection of HPV in high-grade squamous intraepithelial lesion (HSIL), no significant difference was observed between PreTect HPV-Proofer and consensus PCR. For women with a cytologic normal, atypical squamous cell of uncertain significance, and low-grade SIL diagnosis, the detection rate of HPV was significantly higher by Gp5+/6+ consensus PCR (P < 0.005) than by PreTect HPV-Proofer. Histology confirmed 14 of 23 cytologic HSIL as cervical intraepithelial neoplasia grade >2. Of these women, PreTect HPV-Proofer and type-specific PCR detected 12, whereas consensus PCR detected 13. In conclusion, for HSIL, detection of E6/E7 transcripts from HPV types 16, 18, 31, 33, and 45 are present to the same degree as DNA detected by consensus PCR. Equally important, only a small proportion of the HPV DNApositive women with a normal, atypical squamous cell of uncertain significance or low-grade SIL diagnosis had a detectable mRNA expression. HPV E6/E7 mRNA detection by PreTect HPV-Proofer represents a new promising test as an adjunct to cytology.
This article has been cited by other articles:
![]() |
K. Chamany, D. Allen, and K. Tanner Making Biology Learning Relevant to Students: Integrating People, History, and Context into College Biology Teaching CBE Life Sci Educ, September 1, 2008; 7(3): 267 - 278. [Full Text] [PDF] |
||||
![]() |
G. A.V. Boulet, C. A.J. Horvath, S. Berghmans, and J. Bogers Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 810 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Horvath, G Boulet, S Sahebali, J Bogers, C Depuydt, A Vereecken, T Vermeulen, and D Vanden Broeck Effects of fixation on RNA integrity in a liquid-based cervical cytology setting J. Clin. Pathol., January 1, 2008; 61(1): 132 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Castle, J. Dockter, C. Giachetti, F. A.R. Garcia, M. K. McCormick, A. L. Mitchell, E. B. Holladay, and D. P. Kolk A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer Clin. Cancer Res., May 1, 2007; 13(9): 2599 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kraus, T. Molden, R. Holm, A. K. Lie, F. Karlsen, G. B. Kristensen, and H. Skomedal Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas J. Clin. Microbiol., April 1, 2006; 44(4): 1310 - 1317. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |